跳至主要内容
临床试验/ACTRN12623001082695
ACTRN12623001082695尚未招募Unknown

Diagnostic Accuracy of 68Ga-PSMA PET/CT to identify residual Prostate Cancer Following Focal therapy with Irreversible Electroporation for localized Prostate Cancer: A Prospective Study

St Vincent's Private Hospital0 个研究点目标入组 154 人开始时间: 2023年10月12日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
154

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Male

入选标准

  • Male greater or equal to 18 years and over
  • Undergoing primary focal IRE (Nanoknife®) procedure
  • Available mpMRI +/- PSMA PET/CT prior to focal IRE (Nanoknife®) procedure
  • Planned for follow up transperineal biopsy as part of standard clinical follow up at 12-18 months post IRE (Nanoknife®)
  • Willingness to give signed patient information and consent form (PISCF)

排除标准

  • Non-PSMA avid primary lesion on PSMA prior to IRE
  • Unwilling to undergo PSMA PET/CT at 9-12 months
  • Unwilling to undergo follow up transperineal biopsy
  • Unwilling or unable to consent to participation in the study
  • Contraindication to repeat PSMA PET/CT at 9-12 months follow-up

研究者

发起方
St Vincent's Private Hospital

相似试验